Article

The TimesThe Times on 2019-10-13 01:18

$16m for arthritis cell therapy venture

The former boss of gene-editing firm Horizon Discovery has raised $16m (£12.4m) for his new venture, cell therapy start-up Mogrify. Darrin Disley, who ...

Related news